These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36502999)

  • 21. The role of long noncoding RNAs in atrial fibrillation.
    Babapoor-Farrokhran S; Gill D; Rasekhi RT
    Heart Rhythm; 2020 Jun; 17(6):1043-1049. PubMed ID: 31978594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrial remodeling and novel pharmacological strategies for antiarrhythmic therapy in atrial fibrillation.
    Jost N; Kohajda Z; Kristóf A; Kovács PP; Husti Z; Juhász V; Kiss L; Varró A; Virág L; Baczkó I
    Curr Med Chem; 2011; 18(24):3675-94. PubMed ID: 21774760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the initial decline in estimated glomerular filtration rate on the risk of new-onset atrial fibrillation and adverse cardiovascular and renal events in patients with type 2 diabetes treated with sodium-glucose co-transporter-2 inhibitors.
    Chan YH; Chen SW; Chao TF; Kao YW; Huang CY; Chu PH
    Diabetes Obes Metab; 2021 Sep; 23(9):2077-2089. PubMed ID: 34047459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics and Epigenetics of Atrial Fibrillation.
    Lozano-Velasco E; Franco D; Aranega A; Daimi H
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society.
    Lévy S; Steinbeck G; Santini L; Nabauer M; Maceda DP; Kantharia BK; Saksena S; Cappato R
    J Interv Card Electrophysiol; 2022 Oct; 65(1):287-326. PubMed ID: 35419669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.
    Dobrev D
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):195-206. PubMed ID: 19784635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological cardioversion of atrial fibrillation: current management and treatment options.
    Boriani G; Diemberger I; Biffi M; Martignani C; Branzi A
    Drugs; 2004; 64(24):2741-62. PubMed ID: 15563247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression.
    Heijman J; Voigt N; Nattel S; Dobrev D
    Circ Res; 2014 Apr; 114(9):1483-99. PubMed ID: 24763466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial fibrillation: pathophysiology, genetic and epigenetic mechanisms.
    Vinciguerra M; Dobrev D; Nattel S
    Lancet Reg Health Eur; 2024 Feb; 37():100785. PubMed ID: 38362554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial fibrillation in horses part 1: Pathophysiology.
    Decloedt A; Van Steenkiste G; Vera L; Buhl R; van Loon G
    Vet J; 2020 Sep; 263():105521. PubMed ID: 32928494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noncoding RNAs in Atrial Fibrillation: Current Status and Prospect.
    Zhou D; Yang K; Hu J; Shi J; Hu X
    J Cardiovasc Pharmacol; 2020 Jan; 75(1):10-17. PubMed ID: 31895877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic remodeling of intracellular Ca²⁺ signaling during atrial fibrillation.
    Greiser M; Schotten U
    J Mol Cell Cardiol; 2013 May; 58():134-42. PubMed ID: 23298712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective Effects of Sodium-Glucose Transporter 2 Inhibitors on Atrial Fibrillation and Atrial Flutter: A Systematic Review and Meta- Analysis of Randomized Placebo-Controlled Trials.
    Li D; Liu Y; Hidru TH; Yang X; Wang Y; Chen C; Li KHC; Tang Y; Wei Y; Tse G; Xia Y
    Front Endocrinol (Lausanne); 2021; 12():619586. PubMed ID: 33815278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of atrial fibrillation.
    Bajpai A; Savelieva I; Camm AJ
    Br Med Bull; 2008; 88(1):75-94. PubMed ID: 19059992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions.
    Fauchier L; Bisson A; Bodin A
    BMC Med; 2023 Feb; 21(1):54. PubMed ID: 36782248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.
    Singh BN; Mody FV; Lopez B; Sarma JS
    Am J Cardiol; 1999 Nov; 84(9A):161R-173R. PubMed ID: 10568677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart-specific overexpression of (pro)renin receptor induces atrial fibrillation in mice.
    Lian H; Wang X; Wang J; Liu N; Zhang L; Lu Y; Yang Y; Zhang L
    Int J Cardiol; 2015 Apr; 184():28-35. PubMed ID: 25697868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACE I/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural heart disease: implications for electrical remodeling.
    Watanabe H; Kaiser DW; Makino S; MacRae CA; Ellinor PT; Wasserman BS; Kannankeril PJ; Donahue BS; Roden DM; Darbar D
    Heart Rhythm; 2009 Sep; 6(9):1327-32. PubMed ID: 19648063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ion channel dysfunction and fibrosis in atrial fibrillation: Two sides of the same coin.
    Arabia G; Bellicini MG; Cersosimo A; Memo M; Mazzarotto F; Inciardi RM; Cerini M; Chen LY; Aboelhassan M; Benzoni P; Mitacchione G; Bontempi L; Curnis A
    Pacing Clin Electrophysiol; 2024 Mar; 47(3):417-428. PubMed ID: 38375940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.